Graham Capital Management
HCAT icon

Graham Capital Management’s Health Catalyst HCAT Stock Holding History

Graham Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$79.5K Buy
+39,949
New +$57.7K ﹤0.01% 1171
2025
Q4 		– Sell
-10,098
Closed -$28.8K – 1377
2025
Q3 		$28.8K Buy
+10,098
New +$34.6K ﹤0.01% 1205
2025
Q2 		– Sell
-103,401
Closed -$468K – 1412
2025
Q1 		$468K Buy
103,401
+52,070
+101% +$276K 0.01% 841
2024
Q4 		$363K Buy
51,331
+30,668
+148% +$244K 0.01% 853
2024
Q3 		$168K Sell
20,663
-4,167
-17% -$30.1K ﹤0.01% 951
2024
Q2 		$159K Buy
24,830
+223
+0.9% +$1.43K ﹤0.01% 891
2024
Q1 		$185K Buy
+24,607
New +$225K ﹤0.01% 915
2022
Q4 		– Sell
-30,523
Closed -$296K – 1149
2022
Q3 		$296K Buy
30,523
+4,584
+18% +$60.7K 0.01% 908
2022
Q2 		$375K Buy
+25,939
New +$442K 0.02% 757

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Graham Capital Management's HCAT Position: Q2 2026 in Review

Graham Capital Management opened a new position in Health Catalyst (HCAT) in Q2 2026: 39,949 shares worth $79.5K. The stake represents ﹤0.01% of the portfolio and ranks #1171 among its holdings. This is a return to the name: Graham Capital Management previously reported a position in HCAT as recently as Q3 2025.

Graham Capital Management first reported a position in HCAT in Q2 2022 and has held it in 9 quarters since. The position peaked at $468K in Q1 2025. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Graham Capital Management held 39,949 shares of Health Catalyst worth $79.5K as of Q2 2026.
  • Health Catalyst was a new Graham Capital Management position in Q2 2026.
  • Health Catalyst made up ﹤0.01% of Graham Capital Management's portfolio in Q2 2026, its #1171 holding.
  • Graham Capital Management first reported a position in Health Catalyst in Q2 2022 and has held it in 9 quarters since.
  • Graham Capital Management's Health Catalyst position peaked at $468K in Q1 2025.
  • 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.